These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 36551821)

  • 1. Alternative Pharmacological Strategies for the Treatment of Alzheimer's Disease: Focus on Neuromodulator Function.
    Cunliffe G; Lim YT; Chae W; Jung S
    Biomedicines; 2022 Nov; 10(12):. PubMed ID: 36551821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical Discoveries on Multi-Target Approach to Manage Alzheimer's Disease.
    Batool A; Kamal MA; Rizvi SMD; Rashid S
    Curr Drug Metab; 2018; 19(8):704-713. PubMed ID: 29512457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Neuroprotective Strategies using Smart Drug Delivery Systems for Alzheimer's Disease.
    Khan J; Yadav S; Alam MA
    Infect Disord Drug Targets; 2024; 24(3):e231023222565. PubMed ID: 37873911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer's Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?
    Jha SK; Jha NK; Kumar D; Sharma R; Shrivastava A; Ambasta RK; Kumar P
    J Alzheimers Dis; 2017; 57(4):1017-1039. PubMed ID: 27662312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.
    Kashif M; Sivaprakasam P; Vijendra P; Waseem M; Pandurangan AK
    Curr Pharm Des; 2023; 29(43):3428-3441. PubMed ID: 38038007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.
    Han J; Du Z; Lim MH
    Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine: A New Frontier in Alzheimer's Disease Drug Targeting.
    Pathak K; Ahmad MZ; Saikia R; Pathak MP; Sahariah JJ; Kalita P; Das A; Islam MA; Pramanik P; Tayeng D; Abdel-Wahab BA
    Cent Nerv Syst Agents Med Chem; 2024 Mar; ():. PubMed ID: 38551038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in the Treatment of Alzheimer's Disease Using Nanoparticle-Based Drug Delivery Systems.
    Poudel P; Park S
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's Disease Targeted Nano-Based Drug Delivery Systems.
    Altinoglu G; Adali T
    Curr Drug Targets; 2020; 21(7):628-646. PubMed ID: 31744447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptides in Alzheimer's disease: from pathophysiological mechanisms to therapeutic opportunities.
    Van Dam D; Van Dijck A; Janssen L; De Deyn PP
    Curr Alzheimer Res; 2013 Jun; 10(5):449-68. PubMed ID: 23627705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilizing ER Ca2+ channel function as an early preventative strategy for Alzheimer's disease.
    Chakroborty S; Briggs C; Miller MB; Goussakov I; Schneider C; Kim J; Wicks J; Richardson JC; Conklin V; Cameransi BG; Stutzmann GE
    PLoS One; 2012; 7(12):e52056. PubMed ID: 23284867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising Therapies for Alzheimer's Disease.
    Confaloni A; Tosto G; Tata AM
    Curr Pharm Des; 2016; 22(14):2050-6. PubMed ID: 26876218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease.
    Kumar N; Kumar V; Anand P; Kumar V; Ranjan Dwivedi A; Kumar V
    Bioorg Med Chem; 2022 May; 61():116742. PubMed ID: 35398739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.
    Fasae KD; Abolaji AO; Faloye TR; Odunsi AY; Oyetayo BO; Enya JI; Rotimi JA; Akinyemi RO; Whitworth AJ; Aschner M
    J Trace Elem Med Biol; 2021 Sep; 67():126779. PubMed ID: 34034029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 110
    Wechsler ME; Ramirez JEV; Peppas NA
    Ind Eng Chem Res; 2019; 58(33):15079-15087. PubMed ID: 32982041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-Target-Directed Ligands Affecting Serotonergic Neurotransmission for Alzheimer's Disease Therapy: Advances in Chemical and Biological Research.
    Jankowska A; Wesolowska A; Pawlowski M; Chlon-Rzepa G
    Curr Med Chem; 2018; 25(17):2045-2067. PubMed ID: 28554324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New advances in brain-targeting nano-drug delivery systems for Alzheimer's disease.
    Ouyang Q; Meng Y; Zhou W; Tong J; Cheng Z; Zhu Q
    J Drug Target; 2022 Jan; 30(1):61-81. PubMed ID: 33983096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer's Disease and MCI: A Review.
    Rao RV; Subramaniam KG; Gregory J; Bredesen AL; Coward C; Okada S; Kelly L; Bredesen DE
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and emerging avenues for Alzheimer's disease drug targets.
    Loera-Valencia R; Cedazo-Minguez A; Kenigsberg PA; Page G; Duarte AI; Giusti P; Zusso M; Robert P; Frisoni GB; Cattaneo A; Zille M; Boltze J; Cartier N; Buee L; Johansson G; Winblad B
    J Intern Med; 2019 Oct; 286(4):398-437. PubMed ID: 31286586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer's disease.
    Taliyan R; Kakoty V; Sarathlal KC; Kharavtekar SS; Karennanavar CR; Choudhary YK; Singhvi G; Riadi Y; Dubey SK; Kesharwani P
    J Control Release; 2022 Mar; 343():528-550. PubMed ID: 35114208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.